<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39611306</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2055-6845</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular pharmacotherapy</Title><ISOAbbreviation>Eur Heart J Cardiovasc Pharmacother</ISOAbbreviation></Journal><ArticleTitle>Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization study.</ArticleTitle><Pagination><StartPage>136</StartPage><EndPage>142</EndPage><MedlinePgn>136-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjcvp/pvae092</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Large observational and Mendelian randomization (MR) studies have demonstrated a strong association between both elevated LDL cholesterol (LDL-c) and triglycerides (TG) with risk of aortic stenosis (AS), although randomized trials showed no benefit of statins for AS. It consequently remains uncertain whether lipid-lowering therapies have a role to prevent or treat AS. We used a drug-target MR approach to investigate the genetically predicted effect of lipid-lowering therapies on risk of AS.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We collected summary statistics for LDL-c, TG, and AS from genome-wide association studies (GWAS) including 1&#xa0;320&#xa0;016, 1&#xa0;253&#xa0;277, and 412&#xa0;181 European participants from the Global Lipids Genetics Consortium and FinnGen study, respectively. We identified genetic proxies for PCSK9 inhibitors, statins, bempedoic acid, and ezetimibe as single nucleotide polymorphisms in or within 200&#xa0;kb of the target genes (PCSK9, HMGCR, ACLY, and NPC1L1, respectively), which were also significantly associated with LDL-c at P&#xa0;&lt;&#xa0;5&#xa0;&#xd7;&#xa0;10-8. We used a similar approach to identify genetic proxies for the TG-lowering agents fenofibrates, APOC3 inhibitors, and ANGPTL3 inhibitors using the target genes PPARA, APOC3, and ANGPTL3, respectively. Inverse variance-weighted was the primary analysis method. Sensitivity analyses included weighted median, weighted mode, and MR-Egger, followed by the outlier-exclusion approaches MR-PRESSO and Cook's distance. We also performed multivariable analyses to evaluate whether the predicted effect of PCSK9 inhibition may be mediated by lipoprotein(a). We performed replication and negative control analyses using GWAS of AS and height including 653&#xa0;867 and 408&#xa0;112 participants, respectively. Genetically proxied PCSK9 inhibition was significantly associated with reduced AS risk (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.52-0.72, P&#xa0;&lt;&#xa0;0.0001) on main, replication, and all sensitivity analyses. Genetically proxied ezetimibe (OR 0.49, 95% CI 0.31-0.78, P&#xa0;=&#xa0;0.003), bempedoic acid (OR 0.0054, 95% CI 0.0002-0.12, P&#xa0;=&#xa0;0.0009), and statins (OR 0.61, 95% CI 0.46-0.81, P&#xa0;=&#xa0;0.0006) were similarly associated with reduced AS risk, although the latter were not significant on replication analyses. Amongst the TG-lowering agents, genetically proxied APOC3 inhibition was associated with reduced AS risk (OR 0.78, 95% CI 0.70-0.88, P&#xa0;&lt;&#xa0;0.0001), but fenofibrate (OR 0.64, 95% CI 0.09-4.53, P&#xa0;=&#xa0;0.65) and ANGPTL3 inhibitors (OR 1.05, 95% CI 0.77-1.43, P&#xa0;=&#xa0;0.74) were not.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Genetically proxied lipid-lowering therapies are significantly associated with reduced risk of AS. Early initiation and sustained administration of lipid-lowering therapies may prevent AS progression and warrants further research in the clinical trial setting.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciofani</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-4476-6051</Identifier><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Exhibition Rd, South Kensington, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Mathematics and Statistics, University of New South Wales, Sydney 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Karan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Dipender</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7312-7078</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Exhibition Rd, South Kensington, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolf</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1505-2570</Identifier><AffiliationInfo><Affiliation>MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 1TN, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 1QU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychological Science, University of Bristol, Bristol BS8 1QU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimi</LastName><ForeName>Kazem</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Deep Medicine, Oxford Martin School, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Women's and Reproductive Health, Medical Science Division, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allahwala</LastName><ForeName>Usaid K</ForeName><Initials>UK</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhindi</LastName><ForeName>Ravinay</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R79992/CN001</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ES/P011055/1</GrantID><Agency>UKRI</Agency><Country/></Grant><Grant><Agency>Heart Research Australia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Pharmacother</MedlineTA><NlmUniqueID>101669491</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008078">Cholesterol, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000960">Hypolipidemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="C472125">PCSK9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091362">PCSK9 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D000071449">Proprotein Convertase 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008078" MajorTopicYN="Y">Cholesterol, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050171" MajorTopicYN="Y">Dyslipidemias</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000960" MajorTopicYN="Y">Hypolipidemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="Y">Triglycerides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071184" MajorTopicYN="Y">Pharmacogenomic Variants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091362" MajorTopicYN="N">PCSK9 Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000924" MajorTopicYN="Y">Anticholesteremic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071449" MajorTopicYN="N">Proprotein Convertase 9</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic stenosis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Genetic epidemiology</Keyword><Keyword MajorTopicYN="N">Lipid-lowering therapy</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Valvular heart disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>13</Day><Hour>14</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>29</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39611306</ArticleId><ArticleId IdType="pmc">PMC11905763</ArticleId><ArticleId IdType="doi">10.1093/ehjcvp/pvae092</ArticleId><ArticleId IdType="pii">7912555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nazarzadeh &#xa0;M, Pinho-Gomes &#xa0;AC, Bidel &#xa0;Z, Dehghan &#xa0;A, Canoy &#xa0;D, Hassaine &#xa0;A, Ayala Solares &#xa0;JR, Salimi-Khorshidi &#xa0;G, Smith &#xa0;GD, Otto &#xa0;CM, Rahimi &#xa0;K. Plasma lipids and risk of aortic valve stenosis: a mendelian randomization study. Eur Heart J &#xa0;2020;41:3913&#x2013;3920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654932</ArticleId><ArticleId IdType="pubmed">32076698</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundal &#xa0;LJ, Hovland &#xa0;A, Igland &#xa0;J, Veier&#xf8;d &#xa0;MB, Holven &#xa0;KB, Bogsrud &#xa0;MP, Tell &#xa0;GS, Leren &#xa0;TP, Retterst&#xf8;l &#xa0;K. Association of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemia. JAMA Cardiol &#xa0;2019;4:1156&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802245</ArticleId><ArticleId IdType="pubmed">31617858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Kate &#xa0;GR, Bos &#xa0;S, Dedic &#xa0;A, Neefjes &#xa0;LA, Kurata &#xa0;A, Langendonk &#xa0;JG, Liem &#xa0;A, Moelker &#xa0;A, Krestin &#xa0;GP, de Feyter &#xa0;PJ, Roeters van Lennep &#xa0;JE, Nieman &#xa0;K, Sijbrands &#xa0;EJ. Increased aortic valve calcification in familial hypercholesterolemia: prevalence, extent, and associated risk factors. J Am Coll Cardiol &#xa0;2015;66:2687&#x2013;2695.</Citation><ArticleIdList><ArticleId IdType="pubmed">26700830</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossebo &#xa0;AB, Pedersen &#xa0;TR, Boman &#xa0;K, Brudi &#xa0;P, Chambers &#xa0;JB, Egstrup &#xa0;K, Gerdts &#xa0;E, Gohlke-B&#xe4;rwolf &#xa0;C, Holme &#xa0;I, Kes&#xe4;niemi &#xa0;YA, Malbecq &#xa0;W, Nienaber &#xa0;CA, Ray &#xa0;S, Skjaerpe &#xa0;T, Wachtell &#xa0;K, Willenheimer &#xa0;R; &#xa0;SEAS Investigators . Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med &#xa0;2008;359:1343&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">18765433</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowell &#xa0;SJ, Newby &#xa0;DE, Prescott &#xa0;RJ, Bloomfield &#xa0;P, Reid &#xa0;J, Northridge &#xa0;DB, Boon &#xa0;NA; &#xa0;Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators . A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med &#xa0;2005;352:2389&#x2013;2397.</Citation><ArticleIdList><ArticleId IdType="pubmed">15944423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan &#xa0;KL, Teo &#xa0;K, Dumesnil &#xa0;JG, Ni &#xa0;A, Tam &#xa0;J; &#xa0;ASTRONOMER Investigators . Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation &#xa0;2010;121:306&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">20048204</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton &#xa0;J, Bao &#xa0;S, Vanags &#xa0;LZ, Tsatralis &#xa0;T, Ridiandries &#xa0;A, Siu &#xa0;CW, Ng &#xa0;KM, Tan &#xa0;JTM, Celermajer &#xa0;DS, Ng &#xa0;MKC, Bursill &#xa0;CA. Strikingly different atheroprotective effects of apolipoprotein A-I in early- versus late-stage atherosclerosis. JACC Basic Transl Sci &#xa0;2018;3:187&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6059906</ArticleId><ArticleId IdType="pubmed">30062204</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah &#xa0;SM, Shah &#xa0;J, Lakey &#xa0;SM, Garg &#xa0;P, Ripley &#xa0;DP. Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis. Open Heart &#xa0;2023;10:e002244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10040005</ArticleId><ArticleId IdType="pubmed">36963766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sverdlov &#xa0;AL, Ngo &#xa0;DT, Chapman &#xa0;MJ, Ali &#xa0;OA, Chirkov &#xa0;YY, Horowitz &#xa0;JD. Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis &#xa0;2011;1:185&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253493</ArticleId><ArticleId IdType="pubmed">22254198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciofani &#xa0;JL, Han &#xa0;D, Allahwala &#xa0;UK, Bhindi &#xa0;R. Aortic stenosis and renal function: a bidirectional mendelian randomization analysis. JAHA &#xa0;2024;13:e034102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179900</ArticleId><ArticleId IdType="pubmed">38639330</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies &#xa0;NM, Holmes &#xa0;MV, Davey Smith &#xa0;G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ &#xa0;2018;362:k601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciofani &#xa0;JL, Han &#xa0;D, Nazarzadeh &#xa0;M, Allahwala &#xa0;UK, De Maria &#xa0;GL, Banning &#xa0;AP, Bhindi &#xa0;R, Rahimi &#xa0;K. The effect of immunomodulatory drugs on aortic stenosis: a mendelian randomisation analysis. Sci Rep &#xa0;2023;13:18810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620428</ArticleId><ArticleId IdType="pubmed">37914784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill &#xa0;D, Georgakis &#xa0;MK, Walker &#xa0;VM, Schmidt &#xa0;AF, Gkatzionis &#xa0;A, Freitag &#xa0;DF, Finan &#xa0;C, Hingorani &#xa0;AD, Howson &#xa0;JMM, Burgess &#xa0;S, Swerdlow &#xa0;DI, Davey Smith &#xa0;G, Holmes &#xa0;MV, Dichgans &#xa0;M, Scott &#xa0;RA, Zheng &#xa0;J, Psaty &#xa0;BM, Davies &#xa0;NM. Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res &#xa0;2021;6:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903200</ArticleId><ArticleId IdType="pubmed">33644404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference &#xa0;BA, Robinson &#xa0;JG, Brook &#xa0;RD, Catapano &#xa0;AL, Chapman &#xa0;MJ, Neff &#xa0;DR, Voros &#xa0;S, Giugliano &#xa0;RP, Davey Smith &#xa0;G, Fazio &#xa0;S, Sabatine &#xa0;MS. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med &#xa0;2016;375:2144&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959767</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham &#xa0;SE, Clarke &#xa0;SL, Wu &#xa0;KH, Kanoni &#xa0;S, Zajac &#xa0;GJM, Ramdas &#xa0;S, Surakka &#xa0;I, Ntalla &#xa0;I, Vedantam &#xa0;S, Winkler &#xa0;TW, Locke &#xa0;AE, Marouli &#xa0;E, Hwang &#xa0;MY, Han &#xa0;S, Narita &#xa0;A, Choudhury &#xa0;A, Bentley &#xa0;AR, Ekoru &#xa0;K, Verma &#xa0;A, Trivedi &#xa0;B, Martin &#xa0;HC, Hunt &#xa0;KA, Hui &#xa0;Q, Klarin &#xa0;D, Zhu &#xa0;X, Thorleifsson &#xa0;G, Helgadottir &#xa0;A, Gudbjartsson &#xa0;DF, Holm &#xa0;H, Olafsson &#xa0;I, Akiyama &#xa0;M, Sakaue &#xa0;S, Terao &#xa0;C, Kanai &#xa0;M, Zhou &#xa0;W, Brumpton &#xa0;BM, Rasheed &#xa0;H, Ruotsalainen &#xa0;SE, Havulinna &#xa0;AS, Veturi &#xa0;Y, Feng &#xa0;QP, Rosenthal &#xa0;EA, Lingren &#xa0;T, Pacheco &#xa0;JA, Pendergrass &#xa0;SA, Haessler &#xa0;J, Giulianini &#xa0;F, Bradford &#xa0;Y, Miller &#xa0;JE, Campbell &#xa0;A, Lin &#xa0;K, Millwood &#xa0;IY, Hindy &#xa0;G, Rasheed &#xa0;A, Faul &#xa0;JD, Zhao &#xa0;W, Weir &#xa0;DR, Turman &#xa0;C, Huang &#xa0;H, Graff &#xa0;M, Mahajan &#xa0;A, Brown &#xa0;MR, Zhang &#xa0;W, Yu &#xa0;K, Schmidt &#xa0;EM, Pandit &#xa0;A, Gustafsson &#xa0;S, Yin &#xa0;X, Luan &#xa0;J, Zhao &#xa0;J-H, Matsuda &#xa0;F, Jang &#xa0;H-M, Yoon &#xa0;K, Medina-Gomez &#xa0;C, Pitsillides &#xa0;A, Hottenga &#xa0;JJ, Willemsen &#xa0;G, Wood &#xa0;AR, Ji &#xa0;Y, Gao &#xa0;Z, Haworth &#xa0;S, Mitchell &#xa0;RE, Chai &#xa0;JF, Aadahl &#xa0;M, Yao &#xa0;J, Manichaikul &#xa0;A, Warren &#xa0;HR, Ramirez &#xa0;J, Bork-Jensen &#xa0;J, K&#xe5;rhus &#xa0;LL, Goel &#xa0;A, Sabater-Lleal &#xa0;M, Noordam &#xa0;R, Sidore &#xa0;C, Fiorillo &#xa0;E, McDaid &#xa0;AF, Marques-Vidal &#xa0;P, Wielscher &#xa0;M, Trompet &#xa0;S, Sattar &#xa0;N, M&#xf8;llehave &#xa0;LT, Thuesen &#xa0;BH, Munz &#xa0;M, Zeng &#xa0;L, Huang &#xa0;J, Yang &#xa0;B, Poveda &#xa0;A, Kurbasic &#xa0;A, Lamina &#xa0;C, Forer &#xa0;L, Scholz &#xa0;M, Galesloot &#xa0;TE, Bradfield &#xa0;JP, Daw &#xa0;EW, Zmuda &#xa0;JM, Mitchell &#xa0;JS, Fuchsberger &#xa0;C, Christensen &#xa0;H, Brody &#xa0;JA, Feitosa &#xa0;MF, Wojczynski &#xa0;MK, Preuss &#xa0;M, Mangino &#xa0;M, Christofidou &#xa0;P, Verweij &#xa0;N, Benjamins &#xa0;JW, Engmann &#xa0;J, Kember &#xa0;RL, Slieker &#xa0;RC, Lo &#xa0;KS, Zilhao &#xa0;NR, Le &#xa0;P, Kleber &#xa0;ME, Delgado &#xa0;GE, Huo &#xa0;S, Ikeda &#xa0;DD, Iha &#xa0;H, Yang &#xa0;J, Liu &#xa0;J, Leonard &#xa0;HL, Marten &#xa0;J, Schmidt &#xa0;B, Arendt &#xa0;M, Smyth &#xa0;LJ, Ca&#xf1;adas-Garre &#xa0;M, Wang &#xa0;C, Nakatochi &#xa0;M, Wong &#xa0;A, Hutri-K&#xe4;h&#xf6;nen &#xa0;N, Sim &#xa0;X, Xia &#xa0;R, Huerta-Chagoya &#xa0;A, Fernandez-Lopez &#xa0;JC, Lyssenko &#xa0;V, Ahmed &#xa0;M, Jackson &#xa0;AU, Yousri &#xa0;NA, Irvin &#xa0;MR, Oldmeadow &#xa0;C, Kim &#xa0;H-N, Ryu &#xa0;S, Timmers &#xa0;PRHJ, Arbeeva &#xa0;L, Dorajoo &#xa0;R, Lange &#xa0;LA, Chai &#xa0;X, Prasad &#xa0;G, Lor&#xe9;s-Motta &#xa0;L, Pauper &#xa0;M, Long &#xa0;J, Li &#xa0;X, Theusch &#xa0;E, Takeuchi &#xa0;F, Spracklen &#xa0;CN, Loukola &#xa0;A, Bollepalli &#xa0;S, Warner &#xa0;SC, Wang &#xa0;YX, Wei &#xa0;WB, Nutile &#xa0;T, Ruggiero &#xa0;D, Sung &#xa0;YJ, Hung &#xa0;Y-J, Chen &#xa0;S, Liu &#xa0;F, Yang &#xa0;J, Kentistou &#xa0;KA, Gorski &#xa0;M, Brumat &#xa0;M, Meidtner &#xa0;K, Bielak &#xa0;LF, Smith &#xa0;JA, Hebbar &#xa0;P, Farmaki &#xa0;A-E, Hofer &#xa0;E, Lin &#xa0;M, Xue &#xa0;C, Zhang &#xa0;J, Concas &#xa0;MP, Vaccargiu &#xa0;S, van der Most &#xa0;PJ, Pitk&#xe4;nen &#xa0;N, Cade &#xa0;BE, Lee &#xa0;J, van der Laan &#xa0;SW, Chitrala &#xa0;KN, Weiss &#xa0;S, Zimmermann &#xa0;ME, Lee &#xa0;JY, Choi &#xa0;HS, Nethander &#xa0;M, Freitag-Wolf &#xa0;S, Southam &#xa0;L, Rayner &#xa0;NW, Wang &#xa0;CA, Lin &#xa0;S-Y, Wang &#xa0;J-S, Couture &#xa0;C, Lyytik&#xe4;inen &#xa0;L-P, Nikus &#xa0;K, Cuellar-Partida &#xa0;G, Vestergaard &#xa0;H, Hildalgo &#xa0;B, Giannakopoulou &#xa0;O, Cai &#xa0;Q, Obura &#xa0;MO, van Setten &#xa0;J, Li &#xa0;X, Schwander &#xa0;K, Terzikhan &#xa0;N, Shin &#xa0;JH, Jackson &#xa0;RD, Reiner &#xa0;AP, Martin &#xa0;LW, Chen &#xa0;Z, Li &#xa0;L, Highland &#xa0;HM, Young &#xa0;KL, Kawaguchi &#xa0;T, Thiery &#xa0;J, Bis &#xa0;JC, Nadkarni &#xa0;GN, Launer &#xa0;LJ, Li &#xa0;H, Nalls &#xa0;MA, Raitakari &#xa0;OT, Ichihara &#xa0;S, Wild &#xa0;SH, Nelson &#xa0;CP, Campbell &#xa0;H, J&#xe4;ger &#xa0;S, Nabika &#xa0;T, Al-Mulla &#xa0;F, Niinikoski &#xa0;H, Braund &#xa0;PS, Kolcic &#xa0;I, Kovacs &#xa0;P, Giardoglou &#xa0;T, Katsuya &#xa0;T, Bhatti &#xa0;KF, de Kleijn &#xa0;D, de Borst &#xa0;GJ, Kim &#xa0;EK, Adams &#xa0;HHH, Ikram &#xa0;MA, Zhu &#xa0;X, Asselbergs &#xa0;FW, Kraaijeveld &#xa0;AO, Beulens &#xa0;JWJ, Shu &#xa0;X-O, Rallidis &#xa0;LS, Pedersen &#xa0;O, Hansen &#xa0;T, Mitchell &#xa0;P, AW, K&#xe4;h&#xf6;nen &#xa0;M, P&#xe9;russe &#xa0;L, Bouchard &#xa0;C, T&#xf6;njes &#xa0;A, Chen &#xa0;Y-DI, Pennell &#xa0;CE, Mori &#xa0;TA, Lieb &#xa0;W, Franke &#xa0;A, Ohlsson &#xa0;C, Mellstr&#xf6;m &#xa0;D, Cho &#xa0;YS, Lee &#xa0;H, Yuan &#xa0;J-M, Koh &#xa0;W-P, Rhee &#xa0;SY, Woo &#xa0;J-T, Heid &#xa0;IM, Stark &#xa0;KJ, V&#xf6;lzke &#xa0;H, Homuth &#xa0;G, Evans &#xa0;MK, Zonderman &#xa0;AB, Polasek &#xa0;O, Pasterkamp &#xa0;G, Hoefer &#xa0;IE, Redline &#xa0;S, Pahkala &#xa0;K, Oldehinkel &#xa0;AJ, Snieder &#xa0;H, Biino &#xa0;G, Schmidt &#xa0;R, Schmidt &#xa0;H, Chen &#xa0;YE, Bandinelli &#xa0;S, Dedoussis &#xa0;G, Thanaraj &#xa0;TA, Kardia &#xa0;SLR, Kato &#xa0;N, Schulze &#xa0;MB, Girotto &#xa0;G, Jung &#xa0;B, B&#xf6;ger &#xa0;CA, Joshi &#xa0;PK, Bennett &#xa0;DA, Jager &#xa0;PLD, Lu &#xa0;X, Mamakou &#xa0;V, Brown &#xa0;M, Caulfield &#xa0;MJ, Munroe &#xa0;PB, Guo &#xa0;X, Ciullo &#xa0;M, Jonas &#xa0;JB, Samani &#xa0;NJ, Kaprio &#xa0;J, Pajukanta &#xa0;P, Adair &#xa0;LS, Bechayda &#xa0;SA, de Silva &#xa0;HJ, Wickremasinghe &#xa0;AR, Krauss &#xa0;RM, Wu &#xa0;J-Y, Zheng &#xa0;W, den Hollander &#xa0;AI, Bharadwaj &#xa0;D, Correa &#xa0;A, Wilson &#xa0;JG, Lind &#xa0;L, Heng &#xa0;C-K, Nelson &#xa0;AE, Golightly &#xa0;YM, Wilson &#xa0;JF, Penninx &#xa0;B, Kim &#xa0;H-L, Attia &#xa0;J, Scott &#xa0;RJ, Rao &#xa0;DC, Arnett &#xa0;DK, Hunt &#xa0;SC, Walker &#xa0;M, Koistinen &#xa0;HA, Chandak &#xa0;GR, Yajnik &#xa0;CS, Mercader &#xa0;JM, Tusi&#xe9;-Luna &#xa0;T, Aguilar-Salinas &#xa0;CA, Villalpando &#xa0;CG, Orozco &#xa0;L, Fornage &#xa0;M, Tai &#xa0;ES, van Dam &#xa0;RM, Lehtim&#xe4;ki &#xa0;T, Chaturvedi &#xa0;N, Yokota &#xa0;M, Liu &#xa0;J, Reilly &#xa0;DF, McKnight &#xa0;AJ, Kee &#xa0;F, J&#xf6;ckel &#xa0;K-H, McCarthy &#xa0;MI, Palmer &#xa0;CNA, Vitart &#xa0;V, Hayward &#xa0;C, Simonsick &#xa0;E, van Duijn &#xa0;CM, Lu &#xa0;F, Qu &#xa0;J, Hishigaki &#xa0;H, Lin &#xa0;X, M&#xe4;rz &#xa0;W, Parra &#xa0;EJ, Cruz &#xa0;M, Gudnason &#xa0;V, Tardif &#xa0;J-C, Lettre &#xa0;G, 't Hart &#xa0;LM, Elders &#xa0;PJM, Damrauer &#xa0;SM, Kumari &#xa0;M, Kivimaki &#xa0;M, van der Harst &#xa0;P, Spector &#xa0;TD, Loos &#xa0;RJF, Province &#xa0;MA, Psaty &#xa0;BM, Brandslund &#xa0;I, Pramstaller &#xa0;PP, Christensen &#xa0;K, Ripatti &#xa0;S, Wid&#xe9;n &#xa0;E, Hakonarson &#xa0;H, Grant &#xa0;SFA, Kiemeney &#xa0;LALM, de Graaf &#xa0;J, Loeffler &#xa0;M, Kronenberg &#xa0;F, Gu &#xa0;D, Erdmann &#xa0;J, Schunkert &#xa0;H, Franks &#xa0;PW, Linneberg &#xa0;A, Jukema &#xa0;JW, Khera &#xa0;AV, M&#xe4;nnikk&#xf6; &#xa0;M, Jarvelin &#xa0;M-R, Kutalik &#xa0;Z, Cucca &#xa0;F, Mook-Kanamori &#xa0;DO, van Dijk &#xa0;KW, Watkins &#xa0;H, Strachan &#xa0;DP, Grarup &#xa0;N, Sever &#xa0;P, Poulter &#xa0;N, Rotter &#xa0;JI, Dantoft &#xa0;TM, Karpe &#xa0;F, Neville &#xa0;MJ, Timpson &#xa0;NJ, Cheng &#xa0;C-Y, Wong &#xa0;T-Y, Khor &#xa0;CC, Sabanayagam &#xa0;C, Peters &#xa0;A, Gieger &#xa0;C, Hattersley &#xa0;AT, Pedersen &#xa0;NL, Magnusson &#xa0;PKE, Boomsma &#xa0;DI, de Geus &#xa0;EJC, Cupples &#xa0;LA, van Meurs &#xa0;JBJ, Ghanbari &#xa0;M, Gordon-Larsen &#xa0;P, Huang &#xa0;W, Kim &#xa0;YJ, Tabara &#xa0;Y, Wareham &#xa0;NJ, Langenberg &#xa0;C, Zeggini &#xa0;E, Kuusisto &#xa0;J, Laakso &#xa0;M, Ingelsson &#xa0;E, Abecasis &#xa0;G, Chambers &#xa0;JC, Kooner &#xa0;JS, de Vries &#xa0;PS, Morrison &#xa0;AC, North &#xa0;KE, Daviglus &#xa0;M, Kraft &#xa0;P, Martin &#xa0;NG, Whitfield &#xa0;JB, Abbas &#xa0;S, Saleheen &#xa0;D, Walters &#xa0;RG, Holmes &#xa0;MV, Black &#xa0;C, Smith &#xa0;BH, Justice &#xa0;AE, Baras &#xa0;A, Buring &#xa0;JE, Ridker &#xa0;PM, Chasman &#xa0;DI, Kooperberg &#xa0;C, Wei &#xa0;W-Q, Jarvik &#xa0;GP, Namjou &#xa0;B, Hayes &#xa0;MG, Ritchie &#xa0;MD, Jousilahti &#xa0;P, Salomaa &#xa0;V, Hveem &#xa0;K, &#xc5;svold &#xa0;BO, Kubo &#xa0;M, Kamatani &#xa0;Y, Okada &#xa0;Y, Murakami &#xa0;Y, Thorsteinsdottir &#xa0;U, Stefansson &#xa0;K, Ho &#xa0;Y-L, Lynch &#xa0;JA, Rader &#xa0;DJ, Tsao &#xa0;PS, Chang &#xa0;K-M, Cho &#xa0;K, O'Donnell &#xa0;CJ, Gaziano &#xa0;JM, Wilson &#xa0;P, Rotimi &#xa0;CN, Hazelhurst &#xa0;S, Ramsay &#xa0;M, Trembath &#xa0;RC, van Heel &#xa0;DA, Tamiya &#xa0;G, Yamamoto &#xa0;M, Kim &#xa0;B-J, Mohlke &#xa0;KL, Frayling &#xa0;TM, Hirschhorn &#xa0;JN, Kathiresan &#xa0;S, Million Veteran Program &#xa0;VA; &#xa0;Global Lipids Genetics Consortium*; &#xa0;Boehnke &#xa0;M, Natarajan &#xa0;P, Peloso &#xa0;GM, Brown &#xa0;CD, Morris &#xa0;AP, Assimes &#xa0;TL, Deloukas &#xa0;P, Sun &#xa0;YV, Willer CJ. The power of genetic diversity in genome-wide association studies of lipids. Nature &#xa0;2021;600:675&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730582</ArticleId><ArticleId IdType="pubmed">34887591</ArticleId></ArticleIdList></Reference><Reference><Citation>

Neale &#xa0;B. Neale Lab: UK Biobank. http://www.nealelab.is/uk-biobank/ (accessed 4 February 2024).</Citation></Reference><Reference><Citation>Yu Chen &#xa0;H, Dina &#xa0;C, Small &#xa0;AM, Shaffer &#xa0;CM, Levinson &#xa0;RT, Helgad&#xf3;ttir &#xa0;A, Capoulade &#xa0;R, Munter &#xa0;HM, Martinsson &#xa0;A, Cairns &#xa0;BJ, Truds&#xf8; &#xa0;LC, Hoekstra &#xa0;M, Burr &#xa0;HA, Marsh &#xa0;TW, Damrauer &#xa0;SM, Dufresne &#xa0;L, Le Scouarnec &#xa0;S, Messika-Zeitoun &#xa0;D, Ranatunga &#xa0;DK, Whitmer &#xa0;RA, Bonnefond &#xa0;A, Sveinbjornsson &#xa0;G, Dan&#xed;elsen &#xa0;R, Arnar &#xa0;DO, Thorgeirsson &#xa0;G, Thorsteinsdottir &#xa0;U, Gudbjartsson &#xa0;DF, H&#xf3;lm &#xa0;H, Ghouse &#xa0;J, Olesen &#xa0;MS, Christensen &#xa0;AH, Mikkelsen &#xa0;S, Jacobsen &#xa0;RL, Dowsett &#xa0;J, Pedersen &#xa0;OBV, Erikstrup &#xa0;C, Ostrowski &#xa0;SR; &#xa0;Regeneron Genetics Center; O'Donnell &#xa0;CJ, Budoff &#xa0;MJ, Gudnason &#xa0;V, Post &#xa0;WS, Rotter &#xa0;JI, Lathrop &#xa0;M, Bundgaard &#xa0;H, Johansson &#xa0;B, Ljungberg &#xa0;J, N&#xe4;slund &#xa0;U, Le Tourneau &#xa0;T, Smith &#xa0;JG, Wells &#xa0;QS, S&#xf6;derberg &#xa0;S, Stef&#xe1;nsson &#xa0;K, Schott &#xa0;JJ, Rader &#xa0;DJ, Clarke &#xa0;R, Engert &#xa0;JC, Thanassoulis &#xa0;G. Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study. Eur Heart J &#xa0;2023;44:1927&#x2013;1939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232274</ArticleId><ArticleId IdType="pubmed">37038246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki &#xa0;MI, Karjalainen &#xa0;J, Palta &#xa0;P, Sipil&#xe4; &#xa0;TP, Kristiansson &#xa0;K, Donner &#xa0;KM, Reeve &#xa0;MP, Laivuori &#xa0;H, Aavikko &#xa0;M, Kaunisto &#xa0;MA, Loukola &#xa0;A, Lahtela &#xa0;E, Mattsson &#xa0;H, Laiho &#xa0;P, Della Briotta Parolo &#xa0;P, Lehisto &#xa0;AA, Kanai &#xa0;M, Mars &#xa0;N, R&#xe4;m&#xf6; &#xa0;J, Kiiskinen &#xa0;T, Heyne &#xa0;HO, Veerapen &#xa0;K, R&#xfc;eger &#xa0;S, Lemmel&#xe4; &#xa0;S, Zhou &#xa0;W, Ruotsalainen &#xa0;S, P&#xe4;rn &#xa0;K, Hiekkalinna &#xa0;T, Koskelainen &#xa0;S, Paajanen &#xa0;T, Llorens &#xa0;V, Gracia-Tabuenca &#xa0;J, Siirtola &#xa0;H, Reis &#xa0;K, Elnahas &#xa0;AG, Sun &#xa0;B, Foley &#xa0;CN, Aalto-Set&#xe4;l&#xe4; &#xa0;K, Alasoo &#xa0;K, Arvas &#xa0;M, Auro &#xa0;K, Biswas &#xa0;S, Bizaki-Vallaskangas &#xa0;A, Carpen &#xa0;O, Chen &#xa0;CY, Dada &#xa0;OA, Ding &#xa0;Z, Ehm &#xa0;MG, Eklund &#xa0;K, F&#xe4;rkkil&#xe4; &#xa0;M, Finucane &#xa0;H, Ganna &#xa0;A, Ghazal &#xa0;A, Graham &#xa0;RR, Green &#xa0;EM, Hakanen &#xa0;A, Hautalahti &#xa0;M, &#xc5;K &#xa0;H, Hiltunen &#xa0;M, Hinttala &#xa0;R, Hovatta &#xa0;I, Hu &#xa0;X, Huertas-Vazquez &#xa0;A, Huilaja &#xa0;L, Hunkapiller &#xa0;J, Jacob &#xa0;H, Jensen &#xa0;JN, Joensuu &#xa0;H, John &#xa0;S, Julkunen &#xa0;V, Jung &#xa0;M, Junttila &#xa0;J, Kaarniranta &#xa0;K, K&#xe4;h&#xf6;nen &#xa0;M, Kajanne &#xa0;R, Kallio &#xa0;L, K&#xe4;lvi&#xe4;inen &#xa0;R, Kaprio &#xa0;J, FinnGen, Kerimov &#xa0;N, Kettunen &#xa0;J, Kilpel&#xe4;inen &#xa0;E, Kilpi &#xa0;T, Klinger &#xa0;K, Kosma &#xa0;VM, Kuopio &#xa0;T, Kurra &#xa0;V, Laisk &#xa0;T, Laukkanen &#xa0;J, Lawless &#xa0;N, Liu &#xa0;A, Longerich &#xa0;S, M&#xe4;gi &#xa0;R, M&#xe4;kel&#xe4; &#xa0;J, M&#xe4;kitie &#xa0;A, Malarstig &#xa0;A, Mannermaa &#xa0;A, Maranville &#xa0;J, Matakidou &#xa0;A, Meretoja &#xa0;T, Mozaffari &#xa0;SV, Niemi &#xa0;MEK, Niemi &#xa0;M, Niiranen &#xa0;T, Donnell &#xa0;CJO, Obeidat &#xa0;ME, Okafo &#xa0;G, Ollila &#xa0;HM, Palom&#xe4;ki &#xa0;A, Palotie &#xa0;T, Partanen &#xa0;J, Paul &#xa0;DS, Pelkonen &#xa0;M, Pendergrass &#xa0;RK, Petrovski &#xa0;S, Pitk&#xe4;ranta &#xa0;A, Platt &#xa0;A, Pulford &#xa0;D, Punkka &#xa0;E, Pussinen &#xa0;P, Raghavan &#xa0;N, Rahimov &#xa0;F, Rajpal &#xa0;D, Renaud &#xa0;NA, Riley-Gillis &#xa0;B, Rodosthenous &#xa0;R, Saarentaus &#xa0;E, Salminen &#xa0;A, Salminen &#xa0;E, Salomaa &#xa0;V, Schleutker &#xa0;J, Serpi &#xa0;R, Shen &#xa0;H-Y, Siegel &#xa0;R, Silander &#xa0;K, Siltanen &#xa0;S, Soini &#xa0;S, Soininen &#xa0;H, Sul &#xa0;JH, Tachmazidou &#xa0;I, Tasanen &#xa0;K, Tienari &#xa0;P, Toppila-Salmi &#xa0;S, Tukiainen &#xa0;T, Tuomi &#xa0;T, Turunen &#xa0;JA, Ulirsch &#xa0;JC, Vaura &#xa0;F, Virolainen &#xa0;P, Waring &#xa0;J, Waterworth &#xa0;D, Yang &#xa0;R, Nelis &#xa0;M, Reigo &#xa0;A, Metspalu &#xa0;A, Milani &#xa0;L, Esko &#xa0;T, Fox &#xa0;C, Havulinna &#xa0;AS, Perola &#xa0;M, Ripatti &#xa0;S, Jalanko &#xa0;A, Laitinen &#xa0;T, M&#xe4;kel&#xe4; &#xa0;TP, Plenge &#xa0;R, McCarthy &#xa0;M, Runz &#xa0;H, Daly &#xa0;MJ, Palotie &#xa0;A. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature &#xa0;2023;613:508&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9849126</ArticleId><ArticleId IdType="pubmed">36653562</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeler &#xa0;T, Speed &#xa0;D, Porcu &#xa0;E, Pirastu &#xa0;N, Pingault &#xa0;JB, Kutalik &#xa0;Z. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav &#xa0;2023;7:1216&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10365993</ArticleId><ArticleId IdType="pubmed">37106081</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova &#xa0;VW, Richmond &#xa0;RC, Woolf &#xa0;BAR, Yarmolinsky &#xa0;J, Davies &#xa0;NM, Swanson &#xa0;SA, VanderWeele &#xa0;TJ, Higgins &#xa0;JPT, Timpson &#xa0;NJ, Dimou &#xa0;N, Langenberg &#xa0;C, Golub &#xa0;RM, Loder &#xa0;EW, Gallo &#xa0;V, Tybjaerg-Hansen &#xa0;A, Davey Smith &#xa0;G, Egger &#xa0;M, Richards &#xa0;JB. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA &#xa0;2021;326:1614&#x2013;1621.</Citation><ArticleIdList><ArticleId IdType="pubmed">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck &#xa0;M, Chen &#xa0;CY, Neale &#xa0;B, Do &#xa0;R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet &#xa0;2018;50:693&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel &#xa0;A, Ye &#xa0;T, Xue &#xa0;H, Lin &#xa0;Z, Xu &#xa0;S, Woolf &#xa0;B, Mason &#xa0;AM, Burgess &#xa0;S. MendelianRandomization v0.9.0: updates to an R package for performing mendelian randomization analyses using summarized data. Wellcome Open Res &#xa0;2023;8:449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10616660</ArticleId><ArticleId IdType="pubmed">37915953</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf &#xa0;B, Zagkos &#xa0;L, Gill &#xa0;D. TwoStepCisMR: a novel method and R package for attenuating bias in cis-Mendelian randomization analyses. Genes &#xa0;2022;13:1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9498486</ArticleId><ArticleId IdType="pubmed">36140709</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart &#xa0;BF, Siscovick &#xa0;D, Lind &#xa0;BK, Gardin &#xa0;JM, Gottdiener &#xa0;JS, Smith &#xa0;VE, Kitzman &#xa0;DW, Otto &#xa0;CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol &#xa0;1997;29:630&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">9060903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramo &#xa0;J, Jurgens &#xa0;SJ, Kany &#xa0;S, Choi &#xa0;SH, Wang &#xa0;X, Smirnov &#xa0;AN, Friedman &#xa0;SF, Maddah &#xa0;M, Khurshid &#xa0;S, Ellinor &#xa0;PT, Pirruccello &#xa0;JP. Rare genetic variants in LDLR, APOB, and PCSK9 are associated with aortic stenosis. Circulation &#xa0;2024;150:1767&#x2013;1780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11915876</ArticleId><ArticleId IdType="pubmed">39222019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference &#xa0;BA, Ray &#xa0;KK, Catapano &#xa0;AL, Ference &#xa0;TB, Burgess &#xa0;S, Neff &#xa0;DR, Oliver-Williams &#xa0;C, Wood &#xa0;AM, Butterworth &#xa0;AS, Di Angelantonio &#xa0;E, Danesh &#xa0;J, Kastelein &#xa0;JJP, Nicholls &#xa0;SJ. Mendelian randomization study of ACLY and cardiovascular disease. N Engl J Med &#xa0;2019;380:1033&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612927</ArticleId><ArticleId IdType="pubmed">30865797</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael &#xa0;AR, van den Hoogen &#xa0;IJ, Gianni &#xa0;U, Ma &#xa0;X, Tantawy &#xa0;SW, Bax &#xa0;AM, Lu &#xa0;Y, Andreini &#xa0;D, Al-Mallah &#xa0;MH, Budoff &#xa0;MJ, Cademartiri &#xa0;F, Chinnaiyan &#xa0;K, Choi &#xa0;JH, Conte &#xa0;E, Marques &#xa0;H, de &#xa0;A, Gon&#xe7;alves &#xa0;P, Gottlieb &#xa0;I, Hadamitzky &#xa0;M, Leipsic &#xa0;JA, Maffei &#xa0;E, Pontone &#xa0;G, Shin &#xa0;S, Kim &#xa0;YJ, Lee &#xa0;BK, Chun &#xa0;EJ, Sung &#xa0;JM, Lee &#xa0;SE, Virmani &#xa0;R, Samady &#xa0;H, Sato &#xa0;Y, Stone &#xa0;PH, Berman &#xa0;DS, Narula &#xa0;J, Blankstein &#xa0;R, Min &#xa0;JK, Lin &#xa0;FY, Shaw &#xa0;LJ, Bax &#xa0;JJ, Chang &#xa0;HJ. Association of Statin treatment with progression of coronary atherosclerotic plaque composition. JAMA Cardiol &#xa0;2021;6:1257&#x2013;1266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374741</ArticleId><ArticleId IdType="pubmed">34406326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciofani &#xa0;JL, Han &#xa0;D, Allahwala &#xa0;UK, Woolf &#xa0;B, Gill &#xa0;D, Bhindi &#xa0;R. Lipids, blood pressure, and diabetes mellitus on risk of cardiovascular diseases in East Asians: a mendelian randomization study. Am J Cardiol &#xa0;2023;205:329&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615095</ArticleId><ArticleId IdType="pubmed">37633070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>